A woman undergoing cancer treatment will attend a Parkrun to encourage more stem cell donors.
On the forearms of those working in the laboratory at the University of Oslo, one thing stands out: mysterious round or cross ...
Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process ...
The most encouraging results came from studies in mice with damaged retinal blood vessels. When the lab-grown human cells ...
A pioneering stem cell scaffold improved eye surface health and vision in patients with rare aniridia-related keratopathy in ...
Stem cell transplants from younger, more mismatched unrelated donors showed favorable one-year outcomes in a new ACCESS trial ...
Chinese stem cell therapy reverses heart failure in 90% of patients, landmark trial finds - Patients who received treatment ...
A research team from Tel Aviv University and the Leibniz Institute of Polymer Research Dresden (IPF), led by Ayala Lampel and ...
Defying long-held biological rules, an immature "starter" immune cell managed to stay young and divide indefinitely for ...
In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at developing into other cell types, like a younger, fitter version of themselves—by ...
Stem cell therapies are generally safe, well tolerated, and show preliminary potential in slowing functional decline for ...
MIAMI, FL / ACCESS Newswire / August 27, 2026 / , Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results